Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has David L. Porter's publication output changed over time?
ScholarIQpublication output · 1978–2025
Output grew100% over the shown period — from 1 works in 1978 to 2 in 2025.
1
1
1
1
1
1
2
1
2
197819931999200320072019202120242025
What are the most-cited papers on David L. Porter?
ScholarIQmost cited works
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Ginna G. Laport, Bruce L. Levine, Edward A. Stadtmauer, Stephen J. Schuster, Selina M. Luger, Stephan A. Grupp, Nancy Bunin, Frank J. Strobl, Julio Cotte, Zhaohui Zheng, Brian Gregson, Patricia M. Rivers, Robert H. Vonderheide, David Liebowitz, David L. Porter, Carl H. June
Blood. 2003179 CitationsOPEN ACCESS
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L. Nobles, Scott Sherrill-Mix, J.K. Everett, Shantan Reddy, Joseph A. Fraietta, David L. Porter, Noelle V. Frey, Saar Gill, Stephan A. Grupp, Shannon L. Maude, Donald L. Siegel, Bruce L. Levine, Carl H. June, Simon F. Lacey, J. Joseph Melenhorst, Frederic D. Bushman
S114430552. 2019131 CitationsOPEN ACCESS
The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy
David L. Porter, Joseph H. Antin
Annual Review of Medicine. 1999128 Citations
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Pablo Tebas, Julie K. Jadlowsky, Pamela A. Shaw, Lifeng Tian, Erin Esparza, Andrea Brennan, Su Kyung Kim, Soe Yu Naing, Max W. Richardson, Ashley N. Vogel, Colby R. Maldini, Hong Kong, Xiaojun Liu, Simon F. Lacey, Anya M. Bauer, Felicity Mampe, Lee P. Richman, Gary Lee, Dale Ando, Bruce L. Levine, David L. Porter, Yangbing Zhao, Don L. Siegel, Katharine J. Bar, Carl H. June, James L. Riley
S114430552. 202199 CitationsOPEN ACCESS
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
Weimin Kong, Alexander J. Dimitri, Wang Wenliang, In-Young Jung, Christopher J. Ott, Maria Fasolino, Yan Wang, Irina Kulikovskaya, Minnal Gupta, Todd Yoder, Jamie E. DeNizio, J.K. Everett, Erik F. Williams, Jun Xu, John Scholler, Tyler J. Reich, Vijay Bhoj, Kathleen M. Haines, Marcela V. Maus, J. Joseph Melenhorst, Regina M. Young, Julie K. Jadlowsky, Katherine T. Marcucci, James E. Bradner, Bruce L. Levine, David L. Porter, Frederic D. Bushman, Rahul M. Kohli, Carl H. June, Megan M. Davis, Simon F. Lacey, Golnaz Vahedi, Joseph A. Fraietta
S114430552. 202197 CitationsOPEN ACCESS
Related on ScholarIQ
Hospital of the University of Pennsylvania
Institution
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation
Paper
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Paper
The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy
Paper
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication
Paper
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
Paper